What is LOPJLB’s current signal on CADL?

LOPJLB’s latest quantitative signal on Candel Therapeutics, Inc. (CADL) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is CADL in?

Candel Therapeutics, Inc. (CADL) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is Candel Therapeutics, Inc. based / listed?

Candel Therapeutics, Inc. is based in US, listed on NASDAQ.

Candel Therapeutics, Inc. (CADL)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$9.94+2.90%Close

SELLCRISIS · day 9

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $728M
Beta: -0.47
P/E (TTM): -7.00

Short % float: 27.40%
Days to cover: 11.2
SI change: +5.3%

1W: -2.36%
1M: -12.27%

vs SPY 1W: -3.52%
vs SPY 1M: -15.26%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical firm based in Needham, Massachusetts, dedicated to developing innovative immunotherapies for cancer patients. Its pipeline features CAN-2409, which is presently in Phase II clinical trials for pancreatic and lung…

Employees: 55
Headquarters: US
Founded: 2021
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 73.3M
Float: 86.4%

candeltx.com ↗

Key executives

Paul-Peter Tak FOCIS — President, Chief Executive Officer & Director

Seshu Tyagarajan — Chief Technical & Development Officer

Francesca Barone — Chief Scientific Officer

SEC filings

EDGAR · CIK 18413870 · CADL

Analyst consensus

Buy

Bullish10100.0%

Neutral00.0%

Bearish00.0%

L $22.00Avg $22.50H $23.00

Target$22.50+126.36%

Last$9.94

Key stats

Industry peers

Prediction markets

Company news